C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/48 (2006.01) A61K 38/58 (2006.01) C07K 7/64 (2006.01) C07K 14/315 (2006.01) C07K 14/815 (2006.01) C07K 19/00 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 9/48 (2006.01) C12N 9/68 (2006.01) C12N 9/70 (2006.01) C12N 9/72 (2006.01) C12N 15/15 (2006.01) C12N 15/58 (2006.01) C12N 15/81 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2069105
P15586WO ABSTRACT FUSION PROTEINS Relatively inactive fusion proteins are activatable by enzymes of the clotting cascade to have fibrinolytic and/or clot formation inhibition activity. For example, a fusion protein comprising two hirudin or streptokinase molecules, linked by a cleavable linkage sequence, may be cleaved to yield anti-thrombotic hirudin or fibrinolytic streptokinase by thrombin or Factor Xa. Fibrinolytic or clot formation inhibition activity is therefore directed to the site of clot formation.
Czaplewski Lloyd G.
Dawson Keith M.
Hunter Michael G.
British Bio-Technology Limited
Moffat & Co.
LandOfFree
Proteins and nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins and nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins and nucleic acids will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1601203